Nine Chapters Capital Management LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nine Chapters Capital Management LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$61,000
-75.5%
14,600
-59.4%
0.08%
+272.7%
Q3 2015$249,000
+2.5%
36,000
+31.4%
0.02%
+10.0%
Q2 2015$243,000
-67.3%
27,400
-54.8%
0.02%
-68.8%
Q4 2014$742,000
+267.3%
60,600
+127.0%
0.06%
+276.5%
Q2 2014$202,000
+320.8%
26,700
+81.6%
0.02%
+183.3%
Q1 2014$48,00014,7000.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders